CIK 0001062822
- Non-accelerated filer
- Smaller reporting company
LEXICON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- LXRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760474169
- Phone
- +1 281-863-3000
- Business address
- 2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
- Former names
- LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
- 4 Shares withheld for taxes SVP, IR and Corp Comm gave up 74,572 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, General Counsel & Secr. gave up 105,019 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Financial Officer gave up 54,881 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 204,831 shares (to pay taxes)
- 4 Open-market buy Director bought 2,000 shares at $1.49 ($2,980)
- 4 Open-market buy Director bought 100,000 shares at $1.47 ($147,000)
- 4 Open-market buy Director bought 150,000 shares at an average $1.47 ($219,755)
- 4 Grant or award Director acquired 41,289.58 shares (grant or award)
- 4 Open-market buy Director bought 268,497 shares at an average $1.31 ($352,889)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 1,538,462 shares at $1.30 ($2,000,001)
- 3 Insider Initial Statement of Ownership
Page 2 of 34 · 673 filings